Diabetes Drug Evaluation and Biological Testing Services
Introduction: Diabetes is a chronic, metabolic disease resulting from defects in insulin secretion and varying degrees of insulin resistance. Early...
Continue Reading
Introduction: Diabetes is a chronic, metabolic disease resulting from defects in insulin secretion and varying degrees of insulin resistance. Early...
Continue Reading
In the last decade, targeted protein degradation (TPD) technology has become one of the most promising methods to remove specific...
Continue Reading
WuXi AppTec offers a comprehensive platform of in silico drug discovery services to accelerate the process of hit finding and...
Continue Reading
An inevitable challenge emerges over time as tumors develop drug resistance, resulting in treatment failure. The development of targeted therapies...
Continue Reading
OncoWuXi Express: Evaluation of DLL3 CAR-T in SHP-77-Luc Tumor Models Introduction: OncoWuXi Express will continue to keep you informed about...
Continue Reading
Benefiting from more than 15 years of expertise in protein production and structural biology, WuXi Biology’s protein science platform has...
Continue Reading
In addition to identifying chemical starting points for early drug discovery processes, DNA-encoded library (DEL) technology has now expanded to...
Continue Reading
An inevitable challenge emerges over time as tumors develop drug resistance, resulting in treatment failure. This resistance is inherent to...
Continue Reading
Introduction: OncoWuXi Express will continue to keep you informed about updates to our online tumor model database (OncoWuXi Database), as...
Continue Reading